MedPath

Evaluation of Modified Adhesives With Dexcom G6 Sensor

Completed
Conditions
Diabetes
Registration Number
NCT04840446
Lead Sponsor
DexCom, Inc.
Brief Summary

The purpose of the study is to collect and compare information on the performance of CGM adhesives in adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. Age 18 or older;
  2. No previously self-reported adhesive reactions to the any continuous glucose monitor (CGM);
Exclusion Criteria
  1. Extensive skin changes/diseases that preclude wearing the required number of devices (e.g., history of severe reactions from adhesive wear, extensive psoriasis, recent burns or severe sunburn, extensive eczema, extensive scarring, extensive tattoos, dermatitis herpetiformis) at the proposed wear sites;
  2. Current or anticipated use of systemic corticosteroids (oral, injectable, or intravenous)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adhesiveness and survivability of the adhesives10-days

Number of adhesives that survive on the body during wear period

Secondary Outcome Measures
NameTimeMethod
Skin irritation with the adhesives10-days

Proportion of participants who self-report skin irritation during wear period.

Occurrence of adverse events with the adhesives10-days

Highest Draize scale score for adhesive erythema, and edema during wear period. Recorded medical adhesive-related skin injuries (MARSI) and severity during wear period.

Assess user preference or acceptance of the adhesives worn during the study10-days

Final day post-study satisfaction questionnaire (for each adhesive) will be given a score by taking the mean response on the scale 1-5. Satisfaction scores will be tabulated by adhesive.

Trial Locations

Locations (1)

Jaeb Center for Health Research

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath